U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895420) titled 'Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus Subconjunctival Lidocaine (2%): A Randomized, Controlled Trial' on Oct. 19.
Brief Summary: This will be a prospective, randomized, controlled non-inferiority trial comparing the efficacy of Iheezo versus subconjunctival 2% lidocaine in reducing intravitreal injection pain scores up to 24 hours after injection.
Study Start Date: Oct. 30, 2025
Study Type: INTERVENTIONAL
Condition:
No Condition
Intervention:
DRUG: chloroprocaine HCL 3%
Topical anesthetic for intravitreal injection
DRUG: Subconjunctival Lidocaine
Procedural a...